Kiran Vij

Medicine & Life Sciences

1. palbociclib 100%
2. Anastrozole 97%
3. Cyclin-Dependent Kinase 6 96%
4. Cyclin-Dependent Kinase 4 88%
5. Breast Neoplasms 79%
6. Graft vs Host Disease 65%
7. baricitinib 57%
8. thymidine kinase 1 51%
9. MK 2206 51%
10. Plasma Cell Neoplasms 49%
11. Pregnenolone Carbonitrile 49%
12. interferon gamma receptor 47%
13. Fetal Proteins 44%
14. Epithelial Cell Adhesion Molecule 43%
15. DNA Damage 42%
16. Azacitidine 41%
17. Interleukin-6 Receptors 40%
18. Hirschsprung Disease 40%
19. Human T-lymphotropic virus 1 38%
20. DNA Repair 37%
21. Mutagens 36%
22. Drug Therapy 36%
23. Regulatory T-Lymphocytes 36%
24. Cholangiocarcinoma 36%
25. Bone Diseases 34%
26. Spermatogenesis 33%
27. Adult T Cell Leukemia Lymphoma 33%
28. Estrogens 33%
29. Chromatin 31%
30. Neoplasms 31%
31. Serum 30%
32. Phosphorylation 30%
33. Cell Survival 30%
34. Oncogenes 29%
35. Proteolysis 29%
36. Transgenic Mice 27%
37. Cell Biology 27%
38. Mutation 26%
39. Lymphoma 26%
40. Brentuximab Vedotin 25%
41. Adenocarcinoma 24%
42. Patient Care 24%
43. Leukemia 24%
44. Transplants 22%
45. Hematopoietic Stem Cell Transplantation 22%
46. Immunohistochemistry 21%
47. Immunoconjugates 20%
48. Granzymes 20%
49. Hypercalcemia 17%
50. Antibodies 17%